Cargando…
Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients
Viral infections have a major impact on morbidity and mortality of immunosuppressed solid organ transplant (SOT) patients because of missing or failure of adequate pharmacologic antiviral treatment. Adoptive antiviral T-cell therapy (AVTT), regenerating disturbed endogenous T-cell immunity, emerged...
Autores principales: | Amini, Leila, Vollmer, Tino, Wendering, Desiree J., Jurisch, Anke, Landwehr-Kenzel, Sybille, Otto, Natalie Maureen, Jürchott, Karsten, Volk, Hans-Dieter, Reinke, Petra, Schmueck-Henneresse, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546853/ https://www.ncbi.nlm.nih.gov/pubmed/31191530 http://dx.doi.org/10.3389/fimmu.2019.01148 |
Ejemplares similares
-
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients
por: Amini, Leila, et al.
Publicado: (2021) -
The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised
por: Wendering, Desiree J., et al.
Publicado: (2019) -
Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD
por: Landwehr-Kenzel, Sybille, et al.
Publicado: (2021) -
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
por: Roemhild, Andy, et al.
Publicado: (2020) -
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
por: Peter, Lena, et al.
Publicado: (2022)